FDA Inspection 1081766 — Basil T. Darras, M.D.

Basil T. Darras, M.D. — FEI 3015050439

The FDA completed an inspection of Basil T. Darras, M.D. on Feb 12, 2019 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 12, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.